Jane H. Hollingsworth

Insider Reports History

Entity
Individual
Location
Diffusion Pharmaceuticals Inc., 1317 Carlton Avenue, Suite 200, Charlottesville, VA
Signature
/s/ William R. Elder, attorney-in-fact for the Reporting Person
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jane H. Hollingsworth:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CervoMed Inc. Director Common Stock 898 $16.3K $18.16 Aug 31, 2023 Direct
CervoMed Inc. Director Stock Option (Right to Buy) 5.75K Jun 14, 2024 Direct
CervoMed Inc. Director Restricted Stock Unit 0 Aug 31, 2023 Direct

Insider Reports Filed by Jane H. Hollingsworth

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRVO CervoMed Inc. Jun 14, 2024 1 $0 4 Jun 14, 2024 Director
DFFN CervoMed Inc. Sep 15, 2023 1 $0 4 Sep 15, 2023 Director
DFFN CervoMed Inc. Aug 31, 2023 3 $0 4 Sep 6, 2023 Director
DFFN Diffusion Pharmaceuticals Inc. May 31, 2023 3 $0 4 Jun 2, 2023 Director
DFFN Diffusion Pharmaceuticals Inc. Feb 28, 2023 3 $0 4 Mar 3, 2023 Director
DFFN Diffusion Pharmaceuticals Inc. Nov 30, 2022 3 $0 4 Dec 2, 2022 Director
DFFN Diffusion Pharmaceuticals Inc. Aug 31, 2022 3 $0 4 Sep 2, 2022 Director
DFFN Diffusion Pharmaceuticals Inc. May 31, 2022 3 $0 4 Jun 2, 2022 Director
DFFN Diffusion Pharmaceuticals Inc. Jul 1, 2021 1 $0 4 Jul 6, 2021 Director
DFFN Diffusion Pharmaceuticals Inc. May 13, 2021 1 $20K 4 May 17, 2021 Director